易明医药: 半年报董事会决议公告

Group 1 - The third meeting of the board of directors of Tibet Yiming Xiya Pharmaceutical Technology Co., Ltd. was held on August 13, 2025, with all 7 directors present, confirming compliance with relevant laws and regulations [1] - The board unanimously approved the 2025 semi-annual report and its summary, affirming that the report accurately reflects the company's actual situation without any false statements or omissions [2] - The company plans to apply for a comprehensive credit limit of up to RMB 100 million from CITIC Bank's Lhasa branch, with an exposure limit of RMB 80 million and a two-year credit term [2]